Drug details
Firvanq (vancomycin hydrochloride for oral solution)
type of Glycopeptides
Firvanq (vancomycin hydrochloride) is a glycopeptide antibacterial indicated in adults and pediatric patients less than 18 years of age for the treatment of: Clostridium difficile-associated diarrhea, and enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains).
This drug may have the following side effects:
- nausea,
- vomiting,
- diarrhea,
- fever,
- headache
- fatigue,
- abdominal pain,
- low blood potassium (hypokalemia),
- gas,
- swelling of extremities,
- back pain, and
- urinary tract infections (UTIs),
The following drugs are related to Firvanq, either as a replacement or used together:
- Rebyota (fecal microbiota rectal, live - jslm suspension, for rectal use)
- Vowst (fecal microbiota spores, live-brpk capsules)
- Vancocin (vancocin)